0
Athenex, Inc. Banner Image

Athenex, Inc. has reached its limit for free report views

Work for Athenex, Inc.? Upgrade Your Profile and unlock all your annual reports.

Athenex, Inc.

  • Ticker ATNX
    Exchange NASDAQ More
  • Industry Drug Manufacturers - Other More
  • Sector Healthcare More
Athenex, Inc. Logo Image
  • 501-1000 Employees
  • Based in Buffalo, New York
Founded in 2003, Athenex, Inc. is a global clinical stage biopharmaceutical company dedicated to becoming a leader in the discovery, development and commercialization of next generation drugs for the treatment of cancer. Athenex is organized around three platforms, including an Oncology Innovation Platform, a Commercial Platform and a Global Supply Chain Platform. The Company’s currentMore clinical pipeline is derived from four different platform technologies: (1) Orascovery, based on P-glycoprotein inhibitor, (2) Src kinase inhibition, (3) T-cell receptor-engineered T-cells (TCR-T), and (4) Arginine deprivation therapy. Athenex’s employees worldwide are dedicated to improving the lives of cancer patients by creating more active and tolerable treatments. Athenex has offices in Buffalo and Clarence, New York; Cranford, New Jersey; Houston, Texas; Chicago, Illinois; Hong Kong; Taipei, Taiwan; multiple locations in Chongqing, China; Manchester, UK; Guatemala City, Guatemala and Buenos Aires, Argentina.
Athenex, Inc.

Most Recent Annual Report

Athenex, Inc. MOST RECENT 2019 Annual Report and Form 10K

Report Locked. Athenex, Inc. has reached its limit for free report views.

Older/Archived Annual Reports